SuperworthHeartSciences price to book ratio HSCS
Market value divided by the book value of the company's net assets, since 2022.
- Today, Oct 23, 2026
- n/m
- not a meaningful number
- Last meaningful
- 58.5×
- Sep 2026
- 4-year median
- 2.3×
- 4-year range
- 0.3× to 64.3×
- Peer median
- 1.1×
HeartSciences' price to book ratio is not a meaningful number today: shareholders' equity was zero, negative or not reported, so price to book does not exist.
It was last meaningful in Sep 2026, at 58.5×.
On the days it had one over the last 4 years, its median was 2.3×, from 0.3× in Jul 2024 to 64.3× in Sep 2026.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 58.5× | 2.0× | 64.3× |
| 2025 | 2.2× | 0.7× | 37.1× |
| 2024 | 0.9× | 0.3× | 1.0× |
| 2023 | 34.6× | 5.9× | 40.8× |
| 2022 | 6.4× | 3.4× | 7.5× |
Against its peers
Companies in Financial - Credit Services nearest HeartSciences' size, closest first, today.
| Company | Price to book ratio |
|---|---|
| HSCSHeartSciences | n/m |
| BCGBinah Capital | 0.9× |
| VIPVulcan Infrastructure & Power | n/m |
| ATCHAtlasClear | 1.1× |
| RSSSResearch Solutions | 3.2× |
| MACIMelar Acquisition Corp. I/Cayman | n/m |
| Peer median | 1.1× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on HeartSciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.